Procurement Summary
Country: USA
Summary: Notice of Intent to Issue a Sole Source Award for Research and Development of 10, 000 Lateral Flow Devices for Preclinical and Clinical Studies to Rapidly Detect Hiv
Deadline: 03 Jun 2026
Posting Date: 20 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141643120
Document Ref. No.: 75D30126R73455
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The Centers for Disease Control and Prevention Division of HIV Prevention intends to award a sole source firm fixed price purchase order to Beacon Scientific INC for the manufacture of 10, 000 lateral flow devices to be used in pre-clinical and clinical studies evaluating their performance and utility in rapidly detecting HIV antiretroviral usage in point-of-care facilities. This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. NAICS 541714 - Research and Development in Biotechnology (except Nanobiotechnology). Beacon Scientific has proprietary state of the art nanoparticle materials that produce superior results to other LFA design companies making them the only source capable of performing the required work. This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at email [email protected] by 06/02/2026.
Notice ID: 75d30126r73455
Department/Ind. Agency: health and human services, department of
Original Set Aside: total small business set-aside (far 19.5)
Sub-tier: centers for disease control and prevention
Office: cdc office of acquisition services
Product Service Code: aj12 - general science and technology r&d services; general science and technology; applied research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: jun 18, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice